BPCE
AZN icon

Bank Pictet & Cie (Europe)’s AstraZeneca AZN Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Buy
22,759
+2,703
+13% +$508K 0.08% 90
2026
Q1 		$3.89M Buy
+20,056
New +$3.87M 0.08% 91

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Bank Pictet & Cie (Europe)'s AZN Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) increased its AstraZeneca (AZN) stake by 13% in Q2 2026, buying an estimated $508K and bringing the position to 22,759 shares worth $4.26M. The position accounts for 0.08% of the portfolio, ranked #90.

Bank Pictet & Cie (Europe) first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,053 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 22,759 shares of AstraZeneca worth $4.26M as of Q2 2026.
  • Bank Pictet & Cie (Europe) bought 2,703 AstraZeneca shares in Q2 2026, an estimated $508K.
  • AstraZeneca made up 0.08% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #90 holding.
  • Bank Pictet & Cie (Europe) first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,053 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.